NXGLWvs its industry peers
A metric-by-metric comparison of NXGLW against SIC 3841 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NXGLW본 종목 | — | — | — | — | — | — | — | — | — | — | — | — |
| OSRHW | $2M#3 | 0.3x#2 | — | 0.7x#2 | -17.7%#2 | -162.0%#3 | -631.0%#3 | — | — | 2#2 | 24.5%#1 | — |
| IVF | $2M#2 | 0.0x#1 | 0.1x#2 | 0.3x#1 | 4.7%#1 | 157.6%#1 | -105.8%#1 | 141.4%#1 | -44.8%#1 | 5#1 | -97.7%#2 | — |
| SKYAW | $1M#4 | — | 0.0x#1 | 6.2x#4 | — | -2938.9%#5 | -132145.5%#4 | -179.6%#3 | -181.9%#3 | — | — | — |
| MCAGR | $178989#5 | — | — | — | — | -15.1%#2 | — | — | — | — | — | — |
| BDMD | $42M#1 | — | 1.3x#3 | 1.9x#3 | -39.2%#3 | -319.0%#4 | -113.7%#2 | -87.0%#2 | -64.2%#2 | 1#3 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 3841). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice